-
February 24, 2003 Lupin receives USFDA approval for Cefixime Suspension
-
February 13, 2003 Lupin to set up new Lovastatin plant A move to consolidate presence in lifestyle drugs
-
January 28, 2003 Lupin Q3 sales up 19% at Rs. 2868 mn; net profit up 23% at Rs. 227mn
-
October 29, 2002 Lupin Q2 sales up 23% at Rs. 2,985 mn; profit before tax up 35% at Rs. 353 mn
-
July 24, 2002 Lupin Q1 FY03 sales at Rs 2514 million, up 8%; net up 26% at Rs 203 million
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications